Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05361993

Efficacy of Biofeedback in the Treatment of Tic Disorder

Efficacy of Biofeedback in the Treatment of Tic Disorder:A Randomized Controlled Trial

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
8 Years – 16 Years
Healthy volunteers
Not accepted

Summary

To investigate the efficacy of EEG biofeedback and drug therapy in the treatment of tic disorders

Detailed description

This study intends to investigate the efficacy of EEG biofeedback and drug therapy on clinical symptoms, cognitive flexibility and quality of life in chronic tic disorder and Tourette syndrome through a randomized controlled study.

Conditions

Interventions

TypeNameDescription
DRUGDrug AripiprazoleConsidering the patients with chronic tic disorder (chronic motor or vocal tic disorder or Tourette's disorder), aripiprazole was selected as a single drug with constant dose during the treatment. In case of extrapyramidal side effects, benhexol was given to reduce the extrapyramidal side effects, and the dosage and duration of medication were recorded
DEVICEbiofeedbackBiofeedback therapy Biofeedback therapy, three times a week, every other day interval, 30 minutes each time, each subject received 20 biofeedback training(using the Infiniti3000A biofeedback system,Thought Technology Ltd.).Patients in the theta group decreased the theta amplitude at Cz. Patients in the theta group received positive feedback when their theta activity was below the feedback threshold.

Timeline

Start date
2024-06-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2022-05-05
Last updated
2025-01-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05361993. Inclusion in this directory is not an endorsement.